Novel therapy for metastatic kidney cancer developed at VCU Massey and VCU Institute for Molecular Medicine
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.oma and brain, prostate, pancreatic, breast and colon cancers.
VCU Massey discovery could lead to breakthrough for non-small cell lung cancer
Research at Virginia Commonwealth University Massey Cancer Center led by Charles E. Chalfant, Ph.D., associate professor of biochemistry and molecular biology, discovered a previously unknown mechanism in non-small cell lung cancer cells that contributes to their ability to maintain and grow tumors. Narrowing in on this mechanism could provide a breakthrough for the development of effective therapies for NSCLC and other cancers.
New function of gene in promoting cancer found
Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy. By inhibiting the expression of this gene, doctors may have a new viable and effective approach for treating aggressive cancers such as breast, liver and prostate carcinomas, malignant gliomas and neuroblastomas that result from high expression of this cancer-promoting gene.
VCU Massey Cancer Center awarded $2.391 million grant from Virginia Tobacco Commission
Virginia Commonwealth University Massey Cancer Center was recently awarded a two-year, $2.391 million grant from the Virginia Tobacco Indemnification and Community Revitalization Commission (Tobacco Commission) to expand the breadth of the Center's community involvement and grow its state-of-the-art clinical research and cancer specialist delivery system. That delivery system is already in place in communities across Virginia, such as in the Lynchburg, Fredericksburg and Newport News areas.
Knowledge of genetic cancer risks often dies with patients
If you were dying from cancer, would you consider genetic testing? A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill cancer patients who were eligible for genetic testing never received it despite the fact that it could potentially save a relative's life.